Pharma

Fierce Pharma

2nd patient dies after Sarepta's DMD gene therapy Elevidys

Sarepta has suspended giving Elevidys to non-ambulatory DMD patients in the commercial setting while it seeks FDA approval of a risk mitigation plan.

Angus Liu Jun 16, 2025 10:58am

Photo of a final puzzle piece about to fit into a puzzle

NextCure advances ADC pivot with $745M deal for phase 1 drug

Jun 16, 2025 9:52am

liver

South Korean biotech's GLP-1 scores MASH win, reduces weight

Jun 16, 2025 7:22am

weight loss scale weigh measure tape obesity overweight

Lilly's amylin data impress with 11% weight loss, tolerability

Jun 16, 2025 4:55am

Graphic of a drop of blood made up of small data points and nodes

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Jun 13, 2025 1:22pm

AstraZeneca

AstraZeneca pens $5.3B pact with CSPC to develop oral drugs

Jun 13, 2025 5:56am